Real-world outcomes and toxicities of CAR-T in relapsed/refractory follicular lymphoma: a multicenter cohort study

Abstract: Chimeric antigen receptor T-cell therapy has revolutionized the treatment of relapsed/refractory (R/R) follicular lymphoma (FL). Real-world efficacy and toxicity data are needed because clinical trial populations are often unrepresentative. Therefore, we conducted a multicenter retrospecti...

Descrición completa

Detalles Bibliográficos

Principais autores:	John Sharp, Paolo Strati, Subodh Bhatta, Jennifer J. Huang, Colin Thomas, Omar Elghawy, Daniel Reef, Alexander Gorzewski, John Wang, Geoffrey Shouse, Catherine Reinert, Andinet Teferra, Esteban Toro Velez, Ari Pelcovits, Thomas Ollila, William Clark, Victor Yazbeck, Joseph Maakaron, Manali Kamdar, Lindsey Fitzgerald, Alexey Danilov, Reem Karmali, Natalie S. Grover, Stefan K. Barta, Timothy J. Voorhees, Andy I. Chen, Mazyar Shadman, Sairah Ahmed, Narendranath Epperla
Formato:	Artigo
Idioma:	Inglês
Publicado:	Elsevier 2026-06-01
Series:	Blood Advances
Acceso en liña:	http://www.sciencedirect.com/science/article/pii/S2473952926001746
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!